Vimarsana
Biggest News Aggregation in the World

Page 17 - Aid Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aid Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aid Access Today - Breaking & Trending Today

What's at stake in the Supreme Court abortion pill case - Vimarsana News

What's at stake in the Supreme Court abortion pill case

The case could make it harder to get medication abortions even in states where abortion is legal.

Supreme Court again confronts the issue of abortion, this time over access to widely used medication - Vimarsana News

Supreme Court again confronts the issue of abortion, this time over access to widely used medication

WASHINGTON (AP) — The Supreme Court will again wade into the fractious issue of abortion this week when it hears arguments over a medication used in the most common way to end a pregnancy, a case w…

Source: ksn.com
The abortion pill battle is heading to the Supreme Court this week. Here's what to know. - Vimarsana News

The abortion pill battle is heading to the Supreme Court this week. Here's what to know.

The Supreme Court will hear arguments Tuesday in a case challenging a series of actions the FDA took in 2016 and 2021 that made the abortion pill mifepristone easier to obtain.

Supreme Court To Revisit Abortion Debate Amid Medication Access Dispute - Vimarsana News

Supreme Court To Revisit Abortion Debate Amid Medication Access Dispute

The upcoming Supreme Court case on mifepristone access in abortion procedures sparks contentious debates that strike at the heart of the controversial issue.

High court to return to issue of abortion | The Arkansas Democrat-Gazette - Vimarsana News

High court to return to issue of abortion | The Arkansas Democrat-Gazette

Less than two years after the Supreme Court overturned Roe v. Wade, the issue of reproductive rights is returning to the high court on Tuesday as the justices consider whether to limit access to a medication used in more than 60% of U.S. abortions.